Suppr超能文献

11-氧代二十碳四烯酸的细胞摄取和抗增殖作用。

Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.

机构信息

Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, Department of Pharmacology, University of Pennsylvania, Philadelphia, PA.

出版信息

J Lipid Res. 2013 Nov;54(11):3070-7. doi: 10.1194/jlr.M040741. Epub 2013 Aug 14.

Abstract

Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid (oxo-ETE) and 15-oxo-ETE are COX-2/15-PGDH-derived metabolites. Stable isotope dilution (SID) chiral liquid chromatography coupled with electron capture atmospheric pressure chemical ionization (ECAPCI) single reaction monitoring (SRM) MS has been used to quantify uptake of 11-oxo-ETE and 15-oxo-ETE in both LoVo cells and human umbilical vein endothelial cells (HUVEC). Intracellular 11-oxo- and 15-oxo-ETE concentrations reached maximum levels within 1 h and declined rapidly, with significant quantitative differences in uptake between the LoVo cells and the HUVECs. Maximal intracellular concentrations of 11-oxo-ETE were 0.02 ng/4 × 10⁵ cells in the LoVo cells and 0.58 ng/4 × 10⁵ cells in the HUVECs. Conversely, maximal levels of 15-oxo-ETE were 0.21 ng/4 × 10⁵ in the LoVo cells and 0.01 ng/4 × 10⁵ in the HUVECs. The methyl esters of both 11-oxo- and 15-oxo-ETE increased the intracellular concentrations of the corresponding free oxo-ETEs by 3- to 8-fold. 11-oxo-ETE, 15-oxo-ETE, and their methyl esters inhibited proliferation in both HUVECs and LoVo cells at concentrations of 2-10 μM, with 11-oxo-ETE methyl ester being the most potent inhibitor. Cotreatment with probenecid, an inhibitor of multiple drug resistance transporters (MRP)1 and 4, increased the antiproliferative effect of 11-oxo-ETE methyl ester in LoVo cells and increased the intracellular concentration of 11-oxo-ETE from 0.05 ng/4 × 10⁵ cells to 0.18 ng/4 × 10⁵ cells. Therefore, this study has established that the COX-2/15-PGDH-derived eicosanoids 11-oxo- and 15-oxo-ETE enter target cells, that they inhibit cellular proliferation, and that their inhibitory effects are modulated by MRP exporters.

摘要

环氧化酶(COX)将花生四烯酸(AA)代谢为羟二十碳四烯酸(HETE),然后这些 HETE 可被脱氢酶(如 15-羟基前列腺素脱氢酶(15-PGDH))氧化为氧代二十碳四烯酸(ETE)。我们之前已经确定 11-氧代二十碳四烯酸(oxo-ETE)和 15-氧代 ETE 是 COX-2/15-PGDH 衍生的代谢物。稳定同位素稀释(SID)手性液相色谱与电子捕获大气压化学电离(ECAPCI)单反应监测(SRM)MS 已被用于定量测定 LoVo 细胞和人脐静脉内皮细胞(HUVEC)中 11-oxo-ETE 和 15-oxo-ETE 的摄取。细胞内 11-oxo-和 15-oxo-ETE 浓度在 1 小时内达到最高水平,并迅速下降,LoVo 细胞和 HUVEC 之间的摄取存在显著的定量差异。LoVo 细胞中 11-oxo-ETE 的最大细胞内浓度为 0.02 ng/4×10⁵ 个细胞,而 HUVEC 中的最大细胞内浓度为 0.58 ng/4×10⁵ 个细胞。相反,15-oxo-ETE 的最大水平为 0.21 ng/4×10⁵ 个细胞在 LoVo 细胞中,0.01 ng/4×10⁵ 个细胞在 HUVEC 中。11-oxo-和 15-oxo-ETE 的甲酯将相应游离 oxo-ETE 的细胞内浓度提高了 3-8 倍。浓度为 2-10 μM 时,11-oxo-ETE、15-oxo-ETE 及其甲酯均能抑制 HUVEC 和 LoVo 细胞的增殖,其中 11-oxo-ETE 甲酯的抑制作用最强。与丙磺舒(一种多药耐药转运蛋白(MRP)1 和 4 的抑制剂)共同处理可增加 11-oxo-ETE 甲酯在 LoVo 细胞中的抗增殖作用,并将 11-oxo-ETE 的细胞内浓度从 0.05 ng/4×10⁵ 个细胞增加到 0.18 ng/4×10⁵ 个细胞。因此,本研究确定 COX-2/15-PGDH 衍生的类二十烷酸 11-oxo-和 15-oxo-ETE 进入靶细胞,抑制细胞增殖,其抑制作用受 MRP 外排泵调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/3793611/25cbe926542b/3070fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验